- Understanding Informed Consent
- Financial Toxicity: Managing Costs While Enrolled in a Clinical Trial
- What are Solid Tumor Trials and Why Are They Important?
- Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials
- Metastatic Trial Search: New Features
- FDA Fast Track
- Modernizing Clinical Trials
- Just-in-Time Trials
- Expanded Access
- What is a Washout Period?
- What Are “Lines of Therapy”?
- The Right Dose
- Breast Cancer Treatment Vaccines
- MBC, Advanced Breast Cancer & Locally Advanced Breast Cancer: What’s in a Name?
- How Participants are Divided into Treatment Groups in Clinical Trials
- Clinical Trials Are Not Only a “Last Resort”
- How to Find Metastatic Breast Cancer Clinical Trials
- Clinical Trials Primer
- Telemedicine in Clinical Trials
- Do You Know Your Rights as a Cancer Patient?
- Commonly Used Terms in Clinical Trials
- New Features on MTS
- What Do Drug Names Mean?
- Expanding Eligibility Criteria
- OS vs. PFS: What You Need to Know
- New Guideline Includes Immunotherapy
- Best of Inside Clinical Trials (2018-2019)
- Genomic Testing: What Makes Your Tumor Grow?
- Why the Phase of a Clinical Trial Matters
- Patient-Reported Outcomes in Clinical Trials
- What Are Master Protocols?
- All about Basket and Umbrella Trials
SEARCH OUR SITE
for past articles or specific information.